Histological evaluation of the liver of mice with sarcoma-180 treated with salazinic acid

An Acad Bras Cienc. 2023 Apr 3;95(2):e20200455. doi: 10.1590/0001-3765202320200455. eCollection 2023.

Abstract

Many of the drugs used to fight cancer cells induce various damage causing hepatotoxic effects which are characterized by tissue changes. The aim of the study is to know the possible effects of salazinic acid on livers of mice exposed to Sacoma-180. The tumor was grown in the animals in ascitic form and inoculated subcutaneously in the axillary region of the mouse developing the solid tumor. Treatment with salazinic acid (25 and 50 mg/kg) and 5-Fluorouracil (20 mg/kg) started 24-hours after inoculation and was performed for 7 days. To verify these effects, the qualitative method of histological criteria investigated in liver tissue was used. It was observed that all treated groups showed an increase of pyknotic nuclei in relation to the negative control. There was an increase in steatosis in all groups compared to the negative control but there was a decrease in the groups treated with salazinic acid in the 5-Fluorouracil. There was no necrosis in the salazinic acid treated groups. However, this effect was seen in 20% of the positive control group. Therefore, it can be concluded that salazinic acid did not show hepatoprotective action on mice but demonstrated a decrease in steatosis and absence of tissue necrosis.

MeSH terms

  • Animals
  • Fatty Liver*
  • Fluorouracil / pharmacology
  • Liver
  • Mice
  • Sarcoma*

Substances

  • salazinic acid
  • Fluorouracil